Multiple myeloma--intermittent combination chemotherapy compared to continuous therapy
- PMID: 4113171
- DOI: 10.1002/1097-0142(197206)29:6<1665::aid-cncr2820290634>3.0.co;2-4
Multiple myeloma--intermittent combination chemotherapy compared to continuous therapy
Similar articles
-
Intermittent melphalan therapy in multiple myeloma.JAMA. 1969 Jul 14;209(2):251-3. JAMA. 1969. PMID: 5819231 No abstract available.
-
Factors responsible for bone marrow toxicity after treatment of myeloma patients with different alkylating agents.Acta Med Scand. 1978;203(4):276-8. doi: 10.1111/j.0954-6820.1978.tb14872.x. Acta Med Scand. 1978. PMID: 645439
-
Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.Cancer Treat Rep. 1982 Jun;66(6):1273-7. Cancer Treat Rep. 1982. PMID: 7044535 Clinical Trial.
-
[Refractory anemia with partial myeloblastosis in multiple myeloma treated with melphalan].Sem Hop. 1977 Apr 9-16;53(14-15):853-6. Sem Hop. 1977. PMID: 194338 Review. French. No abstract available.
-
[Possibility of using interferon in the treatment of multiple myeloma].Przegl Lek. 1988;45(10):747-50. Przegl Lek. 1988. PMID: 3072590 Review. Polish. No abstract available.
Cited by
-
Melphalan concentration dependent plasma protein binding in healthy humans and rats.Eur J Clin Pharmacol. 1987;32(2):179-85. doi: 10.1007/BF00542192. Eur J Clin Pharmacol. 1987. PMID: 3582482
-
Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.Cancer Chemother Pharmacol. 1988;21(1):1-8. doi: 10.1007/BF00262729. Cancer Chemother Pharmacol. 1988. PMID: 3342460
-
Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.Cancer. 2013 Dec 15;119(24):4308-15. doi: 10.1002/cncr.28340. Epub 2013 Sep 19. Cancer. 2013. PMID: 24105720 Free PMC article. Clinical Trial.
-
Proceedings: The effect of immunosuppression on cancer.Proc Natl Cancer Conf. 1972;7:425-36. Proc Natl Cancer Conf. 1972. PMID: 4587653 Free PMC article. No abstract available.
-
Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.Cancer Chemother Pharmacol. 1991;29(2):89-94. doi: 10.1007/BF00687316. Cancer Chemother Pharmacol. 1991. PMID: 1760863